findmyKOL

Deborah Theodore

Basic profile

Columbia University Irving Medical Center

ORCIDNPI
RegionNew York, NY · NortheastSpecialtyInfectious DiseaseFocusInfectious Disease
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Deborah Theodore is an Infectious Disease physician affiliated with Columbia University Irving Medical Center. OpenAlex indexes 45 publications with 277 citations (h-index 11); ClinicalTrials.gov lists 1 registered study matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
45publications

Distinct works indexed by OpenAlex, matched via ORCID.

277citations

Total citations across indexed works.

11h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

177 Fort Washington Ave
New York, NY 100323733

Telephone

212-305-8039

Provider last certified this registry record 23 Jan 2025.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    25.4%
    Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor10.5%
    Triumeq100%
    Part D<11 patients
    Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor5.3%
    Valacyclovir100%
    Part D<11 patients

    + 4 more classes in this area

  • Cardiovascular

    23.2%
    Statin15.4%
    Atorvastatin Calcium100%
    Part D15 patients
    Calcium channel blocker3.3%
    Amlodipine Besylate100%
    Part D<11 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    20.4%
    Proton pump inhibitor6.7%
    Pantoprazole Sodium55%Omeprazole45%
    Part D<11 patients
    Biguanide (metformin)5.1%
    Metformin Hcl62%Metformin Hcl Er38%
    Part D<11 patients

    + 4 more classes in this area

Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”